Medicared For All Logo

Mark Goldstein MD in Washington, Washington DC

Home Washington DC Washington

Mark Goldstein MD has Hematology/oncology as his primary medical specialty. Their primary office is: 106 Irving St Nw in Washington, Washington DC. There are 2 additional office locations for Mark Goldstein MD that can be viewed towards the end of their profile.

They're a part of the: American Oncology Partners Pa medical group which has around 188 members. You can call their office at 202-726-0941 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2002 (around 22 years of experience). They are listed as doing telehealth appointments.


Mark Goldstein MD Office Phone and Directions

Mark Goldstein MD
American Oncology Partners Pa
106 Irving St Nw
Washington, Washington DC 20010
202-726-0941


Patient Ratings
Please rate your experience with Mark Goldstein MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 202-726-0941


Enter a starting address:


Healthcare Info for Mark Goldstein MD

Medical School: Sorry, his university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Mark Goldstein MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 22
PAC (PECOS ID)#: 1355354135
NPI #: 1649216342
NPI Created On: 06/21/2006
NPI Last Updated Listed as: 02/16/2023
Primary Taxonomy Code: 207R00000X
License Number:
043952
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • CareFirst BlueChoice, Inc.
  • Humana
  • Group Hospitalization and Medical Services Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Arabic.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Transfusion of blood or blood products
  3. Blood test, comprehensive group of blood chemicals
  4. Ferritin (blood protein) level
  5. Iron level
  6. Iron binding capacity
  7. Lactate dehydrogenase (enzyme) level
  8. Complete blood cell count (red cells, white blood cell, platelets), automated test
  9. Red blood count, manual test
  10. Hydration infusion into a vein 31 minutes to 1 hour
  11. Hydration infusion into a vein
  12. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  13. Infusion into a vein for therapy, prevention, or diagnosis
  14. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  15. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  16. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  17. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
  18. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  19. Application of on-body injector for injection under skin
  20. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788516513

Being Disputed:: No

Product Related: No


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788516515

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788516517

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781010601

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781010603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794624529

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794624533

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832156313

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832156341

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832156491

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Additional Office Locations

1. American Oncology Partners Pa
6410 Rockledge Dr
Bethesda, MD 20817
Suite 660
Group Members: 188

Phone: 202-726-0941

Enter a starting address:


2. American Oncology Partners Of Maryland, Pa
6410 Rockledge Dr
Bethesda, MD 20817
Suite 660
Group Members: 11


Enter a starting address:


Hematology/oncology Professionals in Washington

2150 Pennsylvania Ave Nw
Washington, DC
George Washington University Medical Faculty Associates

111 Michigan Ave Nw
Washington, DC
Childrens Hospital

2150 Pennsylvania Ave Nw
Washington, DC
George Washington University Medical Faculty Associates

3800 Reservoir Rd Nw
Washington, DC
Mgmc Llc

3800 Reservoir Rd Nw
Washington, DC
Regional Cancer Care Associates Llc

2041 Georgia Nw Ave
Washington, DC
Howard University

Providers in American Oncology Partners Pa

1.Eugene Agnone

18223 E 10 Mile Rd
Roseville Mi 48066-5821
American Oncology Partners Pa
Medical Oncology

2.Sierra Akinwumi

8301 Harcourt Rd
Indianapolis In 46260-2082
American Oncology Partners Pa
Nurse Practitioner

3.Sierra Akinwumi

1025 Michigan Ave
Logansport In 46947-1593
American Oncology Partners Pa
Nurse Practitioner

4.Jose Alemar Md

3220 N Mcmullen Booth Rd
Clearwater Fl 33761-2012
American Oncology Partners Pa
Hematology/oncology

5.Jose Alemar Md

701 Enterprise Rd E
Safety Harbor Fl 34695-5303
American Oncology Partners Pa
Hematology/oncology

6.Katherine Alexander

3100 Plaza Properties Blvd
Columbus Oh 43219-1530
American Oncology Partners Pa
Nurse Practitioner

View all 188 members of American Oncology Partners Pa medical group